A DNA/HDAC dual‐targeting drug CY190602 with significantly enhanced anticancer potency

Publisher: John Wiley & Sons Inc

E-ISSN: 1757-4684|7|4|438-449

ISSN: 1757-4676

Source: EMBO Molecular Medicine, Vol.7, Iss.4, 2015-04, pp. : 438-449

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract